Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in M2 muscarinic acetylcholine receptor knockout mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 1, 2002, Pages 99-103

  Hemrick Luecke, S K ^b   Bymaster, F P ^a,b   Evans, D C ^a,b   Wess, J ^a   Felder, C C ^b  

^a ELI LILLY AND COMPANY   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 6 (4 BUTYLTHIO 1,2,5 THIADIAZOL 3 YL) 1 AZABICYCLO[3.2.1]OCTANE; CORTICOSTERONE; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR AGONIST; MUSCARINIC M4 RECEPTOR; MUSCARINIC M4 RECEPTOR AGONIST; PERGOLIDE; QUIPAZINE; SCOPOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG RESPONSE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; WILD TYPE;

ANIMALS; CORTICOSTERONE; KINETICS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUSCARINIC AGONISTS; PERGOLIDE; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M4; RECEPTORS, MUSCARINIC; SCOPOLAMINE; TROPANES;

EID: 0036785450     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.036020     Document Type: Article

References (41)

1. Arborelius L, Owens MJ, Plotsky PM, and Nemeroff DB (1999) The role of corticotropin-releasing factor in depression and anxiety disorders. J Endo 160:1-12.
2. Asahina M, Suhara T, Shinotoh H, Inoue O, Suzuki K, and Hattori T (1998) Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study. J Neurol Neurosurg Psychiatry 65:155-163.
3. Avery EE, Baker LD, and Asthana S (1997) Potential role of muscarinic agonists in Alzheimer's disease. Drugs Aging 11:450-459.
4. Bodick NC, Offen W, Levey AI, Cutler NR, Gauthier SG, Satin A, Shannon HE, Tollufson GD, Rasmussen K, Bymaster FP, et al. (1997) Effects of xanomeline, a selective muscarinic receptor agonist on cognitive function and behavioral symptoms in Alzheimer's Disease. Arch Neurol 54:465-473.
5. Bolden C, Cusack B, and Richelson E (1992) Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 260:576-580.
6. Bugajski J, Borycz J, and Gadek-Michalska A (1998) Involvement of the central noradrenergic system in cholinergic stimulation of the pituitary-adrenal response. J Physiol Pharmacol 49:285-292.
7. 4 muscarinic receptor subtypes using receptor knock-out mice. Life Sci 68:2473-2479.
8. Bymaster FP, Shannon HE, Rasmussen K, Delapp NW, Mitch CH, Ward JS, Calligaro DO, Ludvigsen TS, Sheardown MJ, Olesen PH, et al. (1998) Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane. Eur J Pharmacol 356: 109-119.
9. Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, and Chrousos GP (1989) The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanisms. Endocrinology 125:2445-2453.
10. Dilsaver SC (1986) Cholinergic mechanisms in depression. Brain Res 396:285-316.
11. 2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 96:1692-1697.
12. 4 muscarinic receptor knockout mice. Life Sci 24:2457-2466.
13. 4 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 96:10483-10488.
14. Griffiths PD, Perry RH, and Crossman AR (1994) A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease. Neurosci Lett 169:68-71.
15. Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McKnight GS, Idzerda RL, and Nathanson NM (1997) Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci USA 94:13311-13316.
16. Hassey G and Hannin I (1991) The cholinergic-adrenergic hypothesis of depression reexamined using clonidine, metoprolol and physostigmine in an animal model. Biol Psychiatry 29:127-138.
17. Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J, Purohit DP, Bierer LM, and Davis KL (1994) Cortical cholinergic markers in schizophrenia. Schizophr Res 12:137-144.
18. Hedge GA and De Wied D (1971) Corticotropin and vasopressin secretion after hypothalamic implantation of atropine. Endocrinology 88:1257.
19. Janowsky DS, El-Yousef MK, Davis JM, and Sekerke HJ (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 2:632-635.
20. Janowski DS and Overstreet DH (1995) The role of acetylcholine mechanisms in mood disorders, in Psychopharmacology: The Fourth Generation of Progress (Floyd EB and Kupfer DJ eds) Raven Press, New York.
21. Janowsky DS, Risch SC, Kennedy B, Biegler M, and Huey LY (1986) Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release. Psychopharmacology 89:150-154.
22. 5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52:441-448.
23. Levey AI, Kitt CA, Simonds WF, Price DL, and Brann MR (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-selective antibodies. J Neurosci 11:3218-3226.
24. Nemeroff CB (1996) The corticotropin-releasing factor (CRF) hypotheses of depression: new findings and new directions. Mol Psychiatry 1:336-342.
25. Overstreet DH, Daws LC, Schiller GD, Orbach J, and Janowsky DS (1998) Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression. Pharmacol Biochem Behav 59:777-785.
26. Overstreet DH, Jonowsky DA, Gillin JC, Shiromani PJ, and Sutin EL (1986) Stress-induced immobility in rats with cholinergic supersensitivity. Biol Psychiatry 21: 657-664.
27. Pfeiffer CC and Jenney EH (1957) The inhibition of the conditioned response and the counteraction of schizophrenia by muscarinic stimulation of the brain. NY Acad Sci 66:653-664.
28. Rasmussen T, Fink-Jensen A, Sauerberg P, Swedberg MD, Thomsen C, Sheardown MJ, Jeppesen L, Calligaro DO, DeLapp NW, Whitesitt C, et al. (2001) The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance. Schizophr Res 49:193-201.
29. Riemann D, Hohagen F, Bahro M, Lis S, Stadmuller G, Gann H, and Berger M (1994) Cholinergic neurotransmission, REM sleep and depression. J Psychosom Res 38 (Suppl 1):15-25.
30. Risch SC, Janowsky DS, Gillin JC, Rauch JL, Loevinger BL, and Huey LY (1983) Muscarinic supersensitivity of anterior pituitary ACTH release in major depressive illness, adrenal cortical dissociation. Psychopharmacol Bull 19:343-346.
31. 4 muscarinic receptor subtypes in Alzheimer's disease. Synapse 26:341-350.
32. Sauerberg P, Jeppesen L, Olesen PH, Rasmussen T, Swedberg M, Sheardown M, Fink-Jensen A, Thomsen T, Thogersen H, Rimwall K, et al. (1998) Muscarinic agonists with antipsychotic activity: structure activity relationships of 1,2,5-thiazole analogues with functional dopamine agonist activity. J Med Chem 41: 4378-4384.
33. Shannon HE, Bymaster FP, Calligaro DO, DeLapp NW, Jones C, Perry KW, Rasmussen K, Ward JS, Fink-Jensen A, Sheardown M, Jeppesen L, and Sauerberg P (1999) Antipsychotic-like pharmacologic profile of the muscarinic agonist BuTAC. Schizophr Res 36:314.
34. Sithichoke N and Marotta SF (1978) Cholinergic influences on hypothalamic-pituitary-adrenocortical activity of stressed rats: an approach utilizing agonists and antagonists. Acta Endocr 89:726-736.
35. 4 receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro. J Pharmacol Exp Ther 292:877-885.
36. Suda T, Yajima F, Tomori N, Nakagami Y, Ushiyama T, Demura H, and Shizume K (1987) Stimulatory effect of acetylcholine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Life Sci 40:673-677.
37. Wess J (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10:69-99.
38. 5 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 98:14096-14101.
39. 3 muscarinic acetylcholine receptor are hypophagic and lean. Nature (Lond) 410:207-212.
40. 5 receptors in rat brain. Mol Pharmacol 43:149-157.
41. 2 muscarinic receptors are the predominant inhibitory autoreceptors in mouse striatum: a study in muscarinic receptor knockout mice. Soc Neurosci Abstr 25:1724.